Author

Xinyu Wu

Observed name: Wu, Xinyu

Institutions: Capital Medical University, Beijing Anzhen Hospital

Observed institutions: Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Anzhen Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, State Key Laboratory of Molecular Oncology

ORCID: 0000-0002-8980-3736

Observed ORCID: 0000-0002-8980-3736

OpenAlex ID: A5071458117

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers

2023 · Xinyu Wu, Yi Fung Chau, et al. · Frontiers in Oncology · 27

Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1 ‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysis

2022 · Yue Chai, Xinyu Wu, et al. · Thoracic Cancer · 22

Combined Immunotherapy with Chemotherapy versus Bevacizumab with Chemotherapy in First-Line Treatment of Driver-Gene-Negative Non-Squamous Non-Small Cell Lung Cancer: An Updated Systematic Review and Network Meta-Analysis

2022 · Yue Chai, Xinyu Wu, et al. · Journal of Clinical Medicine · 13

Distinct Cross-Vascular Association Patterns of Carotid Plaque Burden and Vulnerability Features with Coronary Atherosclerotic Burden in Patients Undergoing Carotid Revascularization

2026 · Sunan Xu, Zhenjia Wang, et al. · Journal of Clinical Medicine

Works count: 5

Citation count: 57

H-index: 3

I10-index: 3